Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 1105

1.

Aliskiren, Enalapril, or Both in Heart Failure.

McMurray JJ, Dickstein K, Køber LV.

N Engl J Med. 2016 Aug 18;375(7):702. doi: 10.1056/NEJMc1606625. No abstract available.

PMID:
27532843
2.

Variation in hospital performance for heart failure management in the National Heart Failure Audit for England and Wales.

Emdin CA, Conrad N, Kiran A, Salimi-Khorshidi G, Woodward M, Anderson SG, Mohseni H, Dargie HJ, Hardman SM, McDonagh T, McMurray JJ, Cleland JG, Rahimi K.

Heart. 2016 Aug 16. pii: heartjnl-2016-309706. doi: 10.1136/heartjnl-2016-309706. [Epub ahead of print]

PMID:
27530132
3.

Return to the Workforce Following First Hospitalization for Heart Failure: A Danish Nationwide Cohort Study.

Rørth R, Wong C, Kragholm K, Fosbøl E, Mogensen UM, Lamberts M, Petrie MC, Jhund PS, Gerds TA, Torp-Pedersen C, Gislason GH, McMurray JJ, Køber L, Kristensen SL.

Circulation. 2016 Aug 9. pii: CIRCULATIONAHA.116.021859. [Epub ahead of print]

PMID:
27507406
4.

Practical approach on frail older patients attended for acute heart failure.

Martín-Sánchez FJ, Christ M, Miró Ò, Peacock WF, McMurray JJ, Bueno H, Maisel AS, Cullen L, Cowie MR, Di Somma S, Platz E, Masip J, Zeymer U, Vrints C, Price S, Mueller C.

Int J Cardiol. 2016 Jul 18;222:62-71. doi: 10.1016/j.ijcard.2016.07.151. [Epub ahead of print] Review.

PMID:
27458825
5.

Cost-effectiveness Analysis of Sacubitril/Valsartan vs Enalapril in Patients With Heart Failure and Reduced Ejection Fraction.

Gaziano TA, Fonarow GC, Claggett B, Chan WW, Deschaseaux-Voinet C, Turner SJ, Rouleau JL, Zile MR, McMurray JJ, Solomon SD.

JAMA Cardiol. 2016 Jun 22. doi: 10.1001/jamacardio.2016.1747. [Epub ahead of print]

PMID:
27438344
6.

Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme.

Damman K, Solomon SD, Pfeffer MA, Swedberg K, Yusuf S, Young JB, Rouleau JL, Granger CB, McMurray JJ.

Eur J Heart Fail. 2016 Jul 18. doi: 10.1002/ejhf.609. [Epub ahead of print]

PMID:
27427441
7.

Influence of Sacubitril/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure Hospitalization.

Desai AS, Claggett BL, Packer M, Zile MR, Rouleau JL, Swedberg K, Shi V, Lefkowitz M, Starling R, Teerlink J, McMurray JJ, Solomon SD; PARADIGM-HF Investigators.

J Am Coll Cardiol. 2016 Jul 19;68(3):241-8. doi: 10.1016/j.jacc.2016.04.047.

8.

Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation: The PARADIGM-HF Trial.

Solomon SD, Claggett B, Packer M, Desai A, Zile MR, Swedberg K, Rouleau J, Shi V, Lefkowitz M, McMurray JJ.

JACC Heart Fail. 2016 Jun 25. pii: S2213-1779(16)30206-2. doi: 10.1016/j.jchf.2016.05.002. [Epub ahead of print]

9.

End of the Road for Vagus Nerve Stimulation?

McMurray JJ, Køber LV.

J Am Coll Cardiol. 2016 Jul 12;68(2):159-60. doi: 10.1016/j.jacc.2016.05.025. No abstract available.

PMID:
27386768
10.

Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis.

Solomon SD, Claggett B, McMurray JJ, Hernandez AF, Fonarow GC.

Eur J Heart Fail. 2016 Jun 30. doi: 10.1002/ejhf.603. [Epub ahead of print]

PMID:
27364182
11.

Geographic variations in the PARADIGM-HF heart failure trial.

Kristensen SL, Martinez F, Jhund PS, Arango JL, Bĕlohlávek J, Boytsov S, Cabrera W, Gomez E, Hagège AA, Huang J, Kiatchoosakun S, Kim KS, Mendoza I, Senni M, Squire IB, Vinereanu D, Wong RC, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJ.

Eur Heart J. 2016 Jun 28. pii: ehw226. [Epub ahead of print]

PMID:
27354044
12.

Predicting Outcomes Over Time in Patients With Heart Failure, Left Ventricular Systolic Dysfunction, or Both Following Acute Myocardial Infarction.

Lopes RD, Pieper KS, Stevens SR, Solomon SD, McMurray JJ, Pfeffer MA, Leimberger JD, Velazquez EJ.

J Am Heart Assoc. 2016 Jun 27;5(6). pii: e003045. doi: 10.1161/JAHA.115.003045.

13.

Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA).

Arain F, Gullestad L, Nymo S, Kjekshus J, Cleland JG, Michelsen A, McMurray JJ, Wikstrand J, Aukrust P, Ueland T.

Biomarkers. 2016 Jul 12:1-7. [Epub ahead of print]

PMID:
27325138
14.

Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489].

Anker SD, Schroeder S, Atar D, Bax JJ, Ceconi C, Cowie MR, Crisp A, Dominjon F, Ford I, Ghofrani HA, Gropper S, Hindricks G, Hlatky MA, Holcomb R, Honarpour N, Jukema JW, Kim AM, Kunz M, Lefkowitz M, Floch CL, Landmesser U, McDonagh TA, McMurray JJ, Merkely B, Packer M, Prasad K, Revkin J, Rosano GM, Somaratne R, Stough WG, Voors AA, Ruschitzka F.

Eur J Heart Fail. 2016 Jun;18(6):727. doi: 10.1002/ejhf.591. No abstract available.

PMID:
27324688
15.

Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction.

Gandhi PU, Chow SL, Rector TS, Krum H, Gaggin HK, McMurray JJ, Zile MR, Komajda M, McKelvie RS, Carson PE, Januzzi JL Jr, Anand IS.

J Card Fail. 2016 Jun 16. pii: S1071-9164(16)30109-9. doi: 10.1016/j.cardfail.2016.06.006. [Epub ahead of print]

PMID:
27317843
16.

Factors Associated With Noncompletion During the Run-In Period Before Randomization and Influence on the Estimated Benefit of LCZ696 in the PARADIGM-HF Trial.

Desai AS, Solomon S, Claggett B, McMurray JJ, Rouleau J, Swedberg K, Zile M, Lefkowitz M, Shi V, Packer M.

Circ Heart Fail. 2016 Jun;9(6). pii: e002735. doi: 10.1161/CIRCHEARTFAILURE.115.002735.

PMID:
27296397
17.

Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial.

Vardeny O, Claggett B, Packer M, Zile MR, Rouleau J, Swedberg K, Teerlink JR, Desai AS, Lefkowitz M, Shi V, McMurray JJ, Solomon SD; Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Investigators.

Eur J Heart Fail. 2016 Jun 10. doi: 10.1002/ejhf.580. [Epub ahead of print]

PMID:
27283779
18.

The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan.

Jhund PS, McMurray JJ.

Heart. 2016 Sep 1;102(17):1342-7. doi: 10.1136/heartjnl-2014-306775. Epub 2016 May 20. Review.

19.

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; Authors/Task Force Members; Document Reviewers.

Eur J Heart Fail. 2016 Aug;18(8):891-975. doi: 10.1002/ejhf.592. Epub 2016 May 20. No abstract available.

PMID:
27207191
20.

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; Authors/Task Force Members.

Eur Heart J. 2016 Jul 14;37(27):2129-200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20. No abstract available.

PMID:
27206819
Items per page

Supplemental Content

Loading ...
Write to the Help Desk